IMVT Immunovant, Inc. - Common Stock
NASDAQ · Biotechnology · Visualizza su SEC EDGAR ↗ chiudi Ott 2, 2026 10-K/10-Q Ago 6, 2026
$33,62
· % dell'intervallo 52 sett.
· sopra il minimo
· al massimo
$15,95minimo 52 sett.
$45,42massimo 52 sett.
Capitalizzazione di Mercato (MRQ)
$6.93B
P/E
-12.1
EPS
$-2.77
i tuoi badge
Intervallo 52 sett.
$16–$45
Rating Analisti
STRONG BUY
Prezzo Obiettivo
$49
P/E
-12.1
ROE
-73.7%
Margine di Profitto Netto
·
La tua barra dei badge è vuota — aggiungi una metrica a piacere in questa pagina.
IMVT Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$33.62
Capitalizzazione di Mercato (MRQ)
$6.93B
P/E
-12.1
EPS
$-2.77
ROE
-73.7%
Intervallo 52 sett.
$16–$45
IMVT Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
intervallo
barre
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
Performance decennale Andamento di ricavi, utile netto, margini e EPS
EPS$-2.772021-03-31 → 2026-03-31
Flusso di cassa libero$-407M2020-03-31 → 2026-03-31
Margine netto·2023-03-31 → 2024-03-31
Valutazione e Rapporti
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | IMVT | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/E | -12.1media 5 anni ≈-9.1 | ≈-9.1 | · | · | |
| P/S | 351.4media 5 anni ≈216.0 | ≈216.0 | 102.4 | Sopravvalutato | |
| P/B (MRQ) | 9.4media 5 anni ≈4.9 | ≈4.9 | 9.0 | Più costoso | |
| Price / FCF (Prezzo / FCF) | -16.8media 5 anni ≈-11.8 | ≈-11.8 | · | · | |
| Price / Cash Flow (Prezzo / Flusso di cassa) | -16.8media 5 anni ≈-11.8 | ≈-11.8 | · | · | |
| Price / Tangible Book (Prezzo / Valore contabile tangibile) | 8.0media 5 anni ≈4.9 | ≈4.9 | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
| Metrica | Tendenza 5 anni | IMVT | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| ROA | -58.3%media 5 anni ≈-48.7% | ≈-48.7% | -22.4% | Debole | |
| ROE | -73.7%media 5 anni ≈-55.6% | ≈-55.6% | -47.3% | Debole |
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | IMVT | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Rapporto corrente (MRQ) | 7.3media 5 anni ≈11.0 | ≈11.0 | 7.9 | Bassa liquidità | |
| Quick Ratio | 8.6media 5 anni ≈10.5 | ≈10.5 | 6.5 | Liquidità elevata |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
| Metrica | Tendenza 5 anni | IMVT | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Revenue YoY (Ricavi YoY) | 229.2% | · | · | · |
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Nessun dato per questo gruppo di rapporti al momento
Dati fondamentali insufficienti per calcolare questo gruppo di rapporti.
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Tasso di Superamento
25.0%
Sorpresa media
-7.0%
Prossimo report
Nov 09, 2026
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 31 Marzo 2027 | Ago 12, 2026 | $-0.75 | $-0.63 | -19.5% |
| 31 Dicembre 2026 | Mag 20, 2026 | $-0.73 | $-0.61 | -19.1% |
| 30 Giugno 2026 | $-0.75 | $-0.63 | -19.5% | |
| 31 Marzo 2026 | $-0.73 | $-0.61 | -19.1% | |
| 31 Dicembre 2025 | $-0.61 | $-0.73 | 16.3% | |
| 30 Settembre 2025 | $-0.73 | $-0.73 | 0.21% | |
| 30 Giugno 2025 | $-0.71 | $-0.66 | -8.0% | |
| 31 Marzo 2025 | $-0.64 | $-0.73 | 12.4% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | · | · | · | · | $102M | $69M | $48M | $26M | |
| SG&A Expense | $76M | $77M | $57M | $48M | $54M | $40M | $18M | $3M | |
| Operating Expenses | $533M | $438M | $283M | $218M | $156M | $108M | $66M | $28M | |
| Interest Expense | · | · | · | · | · | $0 | $625.0K | · | |
| Other Non-op | $2M | $471.0K | $-1M | $-253.0K | $-781.0K | $328.0K | $412.0K | $-155.0K | |
| Pretax Income | $-505M | $-413M | $-259M | $-211M | $-157M | $-108M | $-66M | $-29M | |
| Income Tax | $215.0K | $891.0K | $567.0K | $9.0K | $-84.0K | $-358.0K | $97.0K | $19.0K | |
| Net Income | $-506M | $-414M | $-259M | $-211M | $-157M | $-107M | $-66M | $-29M | |
| EPS (Basic) | $-2.77 | $-2.73 | $-1.88 | $-1.71 | $-1.43 | $-1.22 | · | · | |
| EPS (Diluted) | $-2.77 | $-2.73 | $-1.88 | $-1.71 | $-1.43 | $-1.22 | · | · | |
| Shares (Basic) | 182,421,233 | 151,573,553 | 138,100,577 | 123,075,329 | 109,679,256 | 87,756,513 | · | · | |
| Shares (Diluted) | 182,421,233 | 151,573,553 | 138,100,577 | 123,075,329 | 109,679,256 | 87,756,513 | · | · |
Stato Patrimoniale
| Metrica | Tendenza | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $902M | $714M | $635M | $377M | $494M | $400M | $101M | $7M | |
| Receivables | $1M | $2M | $5M | $700.0K | $12M | $596.0K | · | · | |
| Prepaid Expense | $46M | $51M | $25M | $27M | $6M | $8M | $5M | $3M | |
| Current Assets | $949M | $768M | $666M | $404M | $513M | $409M | $109M | $13M | |
| PP&E (Net) | $443.0K | $844.0K | $462.0K | $333.0K | $330.0K | $201.0K | $65.0K | $54.0K | |
| Other Non-current Assets | $8M | $8M | $0 | · | · | · | · | · | |
| Total Assets | $957M | $776M | $666M | $406M | $516M | $412M | $109M | $14M | |
| Accounts Payable | $8M | $18M | $7M | $1M | $19M | $2M | $1M | $206.0K | |
| Accrued Liabilities | $97M | $51M | $41M | $40M | $25M | $15M | $11M | $6M | |
| Current Liabilities | $104M | $69M | $49M | $43M | $45M | $19M | $15M | · | |
| Capital Leases | · | · | $0 | $47.0K | $1M | $2M | $0 | · | |
| Total Liabilities | $104M | $69M | $49M | $43M | $46M | $21M | $15M | $6M | |
| Common Stock | $20.0K | $16.0K | $14.0K | $13.0K | $12.0K | $10.0K | $5.0K | $4.0K | |
| Paid-in Capital | $2.60B | $1.95B | $1.44B | $928M | $825M | $590M | $185M | $32M | |
| Retained Earnings | $-1.75B | $-1.24B | $-826M | $-566M | $-355M | $-199M | $-91M | $-25M | |
| AOCI | $730.0K | $1M | $2M | $852.0K | $404.0K | $-298.0K | $-16.0K | $346.0K | |
| Stockholders' Equity | $853M | $707M | $618M | $362M | $470M | $391M | $94M | $7M | |
| Liabilities + Equity | $957M | $776M | $666M | $406M | $516M | $412M | $109M | $14M | |
| Shares Outstanding | 203,940,353 | 170,111,593 | 145,582,999 | 130,329,863 | 116,482,899 | 97,971,243 | 54,655,376 | 38,590,381 |
Flusso di cassa
| Metrica | Tendenza | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $56M | $49M | $41M | $32M | $34M | $19M | $7M | $1M | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Operating Cash Flow | $-407M | $-376M | $-214M | $-188M | $-106M | $-83M | $-53M | $-29M | |
| CapEx | $8.0K | $759.0K | $360.0K | $197.0K | $254.0K | $210.0K | $31.0K | $52.0K | |
| Investing Cash Flow | $-8.0K | $-759.0K | $-360.0K | $-197.0K | $-254.0K | $-210.0K | $-31.0K | $-52.0K | |
| Stock Issued | $544M | $450M | $473M | · | · | · | · | $15M | |
| Net Stock Activity | $544M | · | · | · | · | · | · | · | |
| Financing Cash Flow | $596M | $454M | $472M | $71M | $200M | $383M | $147M | $36M | |
| Net Change in Cash | $188M | $79M | $259M | $-117M | $94M | $300M | $94M | $7M | |
| Taxes Paid | $2M | · | $509.0K | $0 | · | · | · | · | |
| Free Cash Flow | $-407M | $-377M | $-215M | $-188M | $-106M | $-84M | $-53M | · | |
| Levered FCF | · | · | · | · | · | $-84M | $-54M | · |
Redditività
| Metrica | Tendenza | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Net Margin | · | · | -1039.5% | -2783.8% | · | · | · | · | |
| Pretax Margin | · | · | -1037.2% | -2783.7% | · | · | · | · | |
| ROA | -58.3% | -57.4% | -48.4% | -45.8% | -33.8% | -41.2% | -107.8% | · | |
| ROE | -73.7% | -78.1% | -40.0% | -54.3% | -32.1% | -26.7% | -64.5% | · |
Liquidità e Solvibilità
| Metrica | Tendenza | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.1 | 11.2 | 13.7 | 9.3 | 11.5 | 21.8 | · | · | |
| Quick Ratio | 8.6 | 10.4 | 13.2 | 8.7 | 11.4 | 21.3 | · | · |
Efficienza
| Metrica | Tendenza | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | 0.0 | 0.0 | · | · | · | · | |
| Receivables Turnover | · | · | 8.3 | 1.2 | · | · | · | · |
Per Azione
| Metrica | Tendenza | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $4.18 | $4.16 | $4.24 | $2.78 | $4.03 | $4.00 | $1.72 | · | |
| Revenue / Share | · | · | $0.18 | $0.06 | · | · | · | · | |
| Cash Flow / Share | $-2.23 | $-2.48 | $-1.55 | $-1.53 | $-0.97 | · | · | · | |
| Cash / Share | $4.42 | $4.20 | $4.36 | $2.89 | $4.24 | $4.08 | $1.84 | · | |
| EPS (TTM) | $-2.77 | $-2.73 | $-1.88 | $-1.71 | $-1.43 | $-1.22 | · | · |
Tassi di Crescita
| Metrica | Tendenza | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | 229.2% | · | · | · | · | · |
Valutazione (TTM)
| Metrica | Tendenza | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $20M | $20M | $25M | $8M | $0 | · | · | · | |
| Net Income TTM | $-506M | $-414M | $-259M | $-211M | $-157M | $-107M | $-66M | · | |
| Market Cap | $5.07B | $2.91B | $4.70B | $2.02B | $642M | $1.57B | $851M | · | |
| P/E | -9.0 | -6.3 | -17.2 | -9.1 | -3.9 | -13.1 | · | · | |
| P/S | 259.6 | 149.0 | 188.5 | 266.7 | · | · | · | · | |
| P/B | 5.9 | 4.1 | 7.6 | 5.6 | 1.4 | 4.0 | 9.0 | · | |
| P / Tangible Book | 5.9 | 4.1 | 7.6 | 5.6 | 1.4 | 4.0 | · | · | |
| P / Cash Flow | -12.4 | -7.7 | -22.0 | -10.7 | -6.0 | -18.9 | -15.9 | · | |
| P / FCF | -12.4 | -7.7 | -21.9 | -10.7 | -6.0 | -18.8 | -15.9 | · | |
| Earnings Yield | -11.2% | -16.0% | -5.8% | -11.0% | -25.9% | -7.6% | · | · |
Conto Economico
| Metrica | Tendenza | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $38M | $28M | |
| SG&A Expense | $18M | $17M | $15M | $18M | $26M | $20M | $20M | $18M | $19M | $15M | $13M | $14M | $15M | $12M | $12M | $12M | |
| Operating Expenses | $160M | $160M | $114M | $132M | $127M | $114M | $114M | $116M | $94M | $81M | $62M | $62M | $78M | $64M | $50M | $40M | |
| Other Non-op | $4.0K | $798.0K | $-54.0K | $250.0K | $1M | $1M | $-1M | $629.0K | $28.0K | $-3M | $1M | $20.0K | $464.0K | $-2M | $793.0K | $354.0K | |
| Pretax Income | $-153M | $-151M | $-109M | $-126M | $-120M | $-106M | $-111M | $-109M | $-87M | $-75M | $-52M | $-58M | $-74M | $-63M | $-48M | $-40M | |
| Income Tax | $0 | $-3M | $2M | $594.0K | $913.0K | $584.0K | $152.0K | $78.0K | $77.0K | $232.0K | $-108.0K | $454.0K | $-11.0K | $387.0K | $261.0K | $352.0K | |
| Net Income | $-153M | $-148M | $-111M | $-127M | $-121M | $-106M | $-111M | $-109M | $-87M | $-75M | $-51M | $-59M | $-74M | $-63M | $-48M | $-40M | |
| EPS (Basic) | $-0.75 | $-0.72 | $-0.61 | $-0.73 | $-0.71 | $-0.63 | $-0.76 | $-0.74 | $-0.60 | $-0.50 | $-0.36 | $-0.45 | $-0.57 | $-0.49 | $-0.41 | $-0.35 | |
| EPS (Diluted) | $-0.75 | $-0.72 | $-0.61 | $-0.73 | $-0.71 | $-0.63 | $-0.76 | $-0.74 | $-0.60 | $-0.50 | $-0.36 | $-0.45 | $-0.57 | $-0.49 | $-0.41 | $-0.35 | |
| Shares (Basic) | 205,545,373 | · | 181,513,386 | 173,643,829 | 170,872,994 | · | 146,922,338 | 146,468,991 | 146,085,729 | · | 144,523,034 | 131,155,642 | 130,503,264 | 128,574,190 | 116,572,820 | 116,557,508 | |
| Shares (Diluted) | 205,545,373 | · | 181,513,386 | 173,643,829 | 170,872,994 | · | 146,922,338 | 146,468,991 | 146,085,729 | · | 144,523,034 | 131,155,642 | 130,503,264 | 128,574,190 | 116,572,820 | 116,557,508 |
Stato Patrimoniale
| Metrica | Tendenza | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $798M | $902M | $995M | $522M | $599M | $714M | $375M | $473M | $560M | $635M | $691M | $270M | $330M | $433M | $406M | $427M | |
| Receivables | $697.0K | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $5M | $1M | $1M | $823.0K | $704.0K | $4M | $13M | |
| Prepaid Expense | $53M | $43M | $47M | $50M | $51M | $51M | $36M | $33M | $27M | $25M | $19M | $20M | $19M | $21M | $17M | $16M | |
| Current Assets | $851M | $949M | $1.04B | $574M | $652M | $768M | $413M | $507M | $589M | $666M | $711M | $291M | $350M | $454M | $426M | $456M | |
| PP&E (Net) | $351.0K | $443.0K | $531.0K | $632.0K | $737.0K | $844.0K | $752.0K | $671.0K | $565.0K | $462.0K | $376.0K | $304.0K | $325.0K | $362.0K | $312.0K | $328.0K | |
| Other Non-current Assets | $961.0K | $8M | $9M | $9M | $9M | $8M | $8M | $8M | · | $0 | · | · | · | · | · | · | |
| Total Assets | $852M | $957M | $1.05B | $583M | $661M | $776M | $421M | $516M | $590M | $666M | $711M | $292M | $351M | $456M | $428M | $459M | |
| Accounts Payable | $10M | $8M | $9M | $7M | $8M | $18M | $20M | $21M | $11M | $7M | $4M | $8M | $26M | $14M | $7M | $1M | |
| Accrued Liabilities | · | $97M | · | · | · | $51M | $48M | $46M | $34M | $41M | $28M | $32M | $24M | $26M | $23M | $19M | |
| Current Liabilities | $117M | $104M | $66M | $63M | $53M | $69M | $68M | $67M | $45M | $49M | $32M | $40M | $51M | $41M | $32M | $21M | |
| Capital Leases | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $306.0K | $614.0K | $919.0K | |
| Total Liabilities | $117M | $104M | $66M | $63M | $53M | $69M | $68M | $67M | $45M | $49M | $32M | $40M | $51M | $42M | $32M | $22M | |
| Common Stock | $20.0K | $20.0K | $20.0K | $17.0K | $16.0K | $16.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $13.0K | $13.0K | $13.0K | $12.0K | $12.0K | |
| Paid-in Capital | $2.63B | $2.60B | $2.58B | $2.00B | $1.97B | $1.95B | $1.48B | $1.47B | $1.46B | $1.44B | $1.43B | $950M | $940M | $920M | $841M | $833M | |
| Retained Earnings | $-1.90B | $-1.75B | $-1.60B | $-1.49B | $-1.36B | $-1.24B | $-1.13B | $-1.02B | $-913M | $-826M | $-750M | $-699M | $-640M | $-507M | $-444M | $-396M | |
| AOCI | $725.0K | $730.0K | $1M | $1M | $2M | $1M | $2M | $2M | $2M | $2M | $-600.0K | $513.0K | $582.0K | $1M | $-1M | $-263.0K | |
| Stockholders' Equity | $735M | $853M | $986M | $520M | $609M | $707M | $353M | $449M | $545M | $618M | $679M | $252M | $300M | $415M | $396M | $436M | |
| Liabilities + Equity | $852M | $957M | $1.05B | $583M | $661M | $776M | $421M | $516M | $590M | $666M | $711M | $292M | $351M | $456M | $428M | $459M | |
| Shares Outstanding | 206,264,878 | 203,940,353 | 203,316,885 | 174,532,710 | 171,069,176 | 170,111,593 | 147,203,565 | 146,565,049 | 146,195,673 | 145,582,999 | 145,094,052 | 131,442,024 | 130,565,429 | 129,260,254 | 116,614,088 | 116,524,158 |
Flusso di cassa
| Metrica | Tendenza | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $14M | $11M | $13M | $13M | $19M | $12M | $12M | $13M | $13M | $10M | $10M | $11M | $11M | $9M | $8M | $8M | |
| Operating Cash Flow | $-124M | $-95M | $-92M | $-103M | $-117M | $-111M | $-100M | $-89M | $-76M | $-60M | $-47M | $-60M | $-47M | $-46M | $-20M | $-66M | |
| CapEx | · | $8.0K | $0 | $0 | $0 | $201.0K | $180.0K | $196.0K | $182.0K | $150.0K | $131.0K | $34.0K | $45.0K | $98.0K | $31.0K | $42.0K | |
| Investing Cash Flow | · | $-8.0K | $0 | $0 | $0 | $-201.0K | $-180.0K | $-196.0K | $-182.0K | $-150.0K | $-131.0K | $-34.0K | $-45.0K | $-98.0K | $-31.0K | $-42.0K | |
| Stock Issued | · | $0 | · | · | · | $450M | · | · | · | · | · | · | · | $70M | · | · | |
| Financing Cash Flow | $20M | $4M | $565M | $25M | $3M | $451M | $2M | $730.0K | $686.0K | $2M | $470M | $148.0K | $890.0K | $71M | $0 | $21.0K | |
| Net Change in Cash | $-104M | $-92M | $473M | $-77M | $-115M | $339M | $-98M | $-87M | $-75M | $-56M | $421M | $-60M | $-47M | $27M | $-21M | $-67M | |
| Free Cash Flow | · | · | · | · | $-117M | · | · | · | $-76M | · | · | · | $-47M | · | · | $-66M |
Redditività
| Metrica | Tendenza | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | · | · | · | · | · | · | · | · | · | · | -575.6% | -1642.3% | -1818.9% | -2147.7% | -4153.2% | · | |
| Pretax Margin | · | · | · | · | · | · | · | · | · | · | -576.8% | -1629.6% | -1819.1% | -2134.5% | -4130.6% | · | |
| ROA | -20.2% | · | -15.0% | -23.0% | -19.3% | · | -19.6% | -27.0% | -18.5% | · | -8.8% | -16.3% | -18.3% | -12.7% | -9.6% | -9.5% | |
| ROE | -22.8% | · | -16.5% | -26.1% | -20.9% | · | -21.5% | -31.1% | -20.6% | · | -9.4% | -18.1% | -20.1% | -13.8% | -10.3% | -10.1% |
Liquidità e Solvibilità
| Metrica | Tendenza | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.3 | · | 15.7 | 9.1 | 12.3 | · | 6.0 | 7.6 | 13.1 | · | 22.1 | 7.2 | 6.8 | 11.0 | 13.4 | 21.5 | |
| Quick Ratio | 6.8 | · | 15.0 | 8.3 | 11.4 | · | 5.5 | 7.1 | 12.5 | · | 21.6 | 6.7 | 6.4 | 10.5 | 12.9 | 20.7 |
Efficienza
| Metrica | Tendenza | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | |
| Receivables Turnover | · | · | · | · | · | · | · | · | · | · | 10.3 | 1.4 | 0.6 | 8.4 | 0.6 | · |
Per Azione
| Metrica | Tendenza | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.57 | · | $4.85 | $2.98 | $3.56 | · | $2.40 | $3.06 | $3.73 | · | $4.68 | $1.92 | $2.30 | $3.21 | $3.39 | $3.75 | |
| Revenue / Share | · | · | · | · | · | · | · | · | · | · | $0.06 | $0.03 | $0.03 | $0.02 | $0.01 | · | |
| Cash Flow / Share | $-0.61 | · | · | · | $-0.69 | · | · | · | $-0.52 | · | · | · | $-0.36 | · | · | $-0.56 | |
| Cash / Share | $3.87 | · | $4.89 | $2.99 | $3.50 | · | $2.55 | $3.23 | $3.83 | · | $4.76 | $2.05 | $2.53 | $3.35 | $3.48 | $3.67 | |
| EPS (TTM) | $-2.81 | · | $-2.68 | $-2.83 | $-2.84 | · | $-2.60 | $-2.20 | $-1.91 | · | $-1.84 | $-1.97 | $-1.93 | $-1.66 | $-1.53 | $-1.47 |
Valutazione (TTM)
| Metrica | Tendenza | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | · | · | · | · | · | · | · | · | $4M | $1M | $0 | |
| Net Income TTM | $-538M | · | $-464M | $-465M | $-447M | · | $-383M | $-323M | $-273M | · | $-243M | $-255M | $-245M | $-199M | $-177M | $-167M | |
| Market Cap | $7.95B | · | $5.17B | $2.81B | $2.74B | · | $3.65B | $4.18B | $3.86B | · | $6.11B | $5.05B | $2.48B | $2.29B | $651M | $454M | |
| P/E | -13.7 | · | -9.5 | -5.7 | -5.6 | · | -9.5 | -13.0 | -13.8 | · | -22.9 | -19.5 | -9.8 | -10.7 | -3.6 | -2.7 | |
| P/S | · | · | · | · | · | · | · | · | · | · | · | · | · | 559.9 | 563.9 | · | |
| P/B | 10.8 | · | 5.2 | 5.4 | 4.5 | · | 10.3 | 9.3 | 7.1 | · | 9.0 | 20.0 | 8.3 | 5.5 | 1.6 | 1.0 | |
| P / Tangible Book | 10.8 | · | 5.2 | 5.4 | 4.5 | · | 10.3 | 9.3 | 7.1 | · | 9.0 | 20.0 | 8.3 | 5.5 | 1.6 | 1.0 | |
| P / Cash Flow | -63.9 | · | · | · | -23.3 | · | · | · | -50.7 | · | · | · | -52.3 | · | · | -6.9 | |
| Earnings Yield | -7.3% | · | -10.5% | -17.6% | -17.8% | · | -10.5% | -7.7% | -7.2% | · | -4.4% | -5.1% | -10.2% | -9.3% | -27.4% | -37.7% |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Utile netto | $-506M | $-414M | $-259M | $-211M | $-157M |
| EPS Diluito | $-2.77 | $-2.73 | $-1.88 | $-1.71 | $-1.43 |
| Metrica | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Rapporto corrente | 9.1 | 11.2 | 13.7 | 9.3 | 11.5 |
| Quick Ratio | 8.6 | 10.4 | 13.2 | 8.7 | 11.4 |
| Metrica | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Flusso di cassa libero | $-407M | $-377M | $-215M | $-188M | $-106M |
Proprietari istituzionali (13F) 246 filer · $4.4B totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Detentori
246
Valore detenuto
$4.4B
Nuove posizioni
41
Posizioni chiuse
21
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 41 (-8 vs trimestre precedente) | 21 (-2 vs trimestre precedente) | 75 (-19 vs trimestre precedente) | 81 (+37 vs trimestre precedente) | +645K |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| FMR LLC | $623.664.634 | 16.186.469 | 14,33% | Azioni |
| Deep Track Capital, LP | $359.914.548 | 9.341.151 | 8,27% | Azioni |
| BlackRock, Inc. | $276.679.973 | 7.180.897 | 6,36% | Azioni |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $223.666.650 | 5.805.000 | 5,14% | Azioni |
| BAKER BROS. ADVISORS LP | $209.419.027 | 5.435.220 | 4,81% | Azioni |
| VANGUARD GROUP INC | $197.750.162 | 7.779.314 | 4,54% | Azioni |
| STATE STREET CORP | $177.893.203 | 4.617.005 | 4,09% | Azioni |
| MORGAN STANLEY | $174.727.164 | 4.534.833 | 4,01% | Azioni |
| TCG Crossover Management, LLC | $171.766.278 | 4.457.988 | 3,95% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $150.671.912 | 3.910.509 | 3,46% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $140.198.379 | 3.638.681 | 3,22% | Azioni |
| JENNISON ASSOCIATES LLC | $127.543.468 | 3.310.238 | 2,93% | Azioni |
| RTW INVESTMENTS, LP | $122.442.522 | 3.177.849 | 2,81% | Azioni |
| Two Seas Capital LP | $121.311.898 | 3.148.505 | 2,79% | Azioni |
| ADAR1 Capital Management, LLC | $89.802.487 | 2.330.716 | 2,06% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $86.115.373 | 2.234.602 | 1,98% | Azioni |
| Woodline Partners LP | $76.130.233 | 1.975.869 | 1,75% | Azioni |
| GOLDMAN SACHS GROUP INC | $67.473.081 | 1.751.183 | 1,55% | Azioni |
| ARMISTICE CAPITAL, LLC | $66.888.080 | 1.736.000 | 1,54% | Azioni |
| Alpine Global Management, LLC | $52.978.748 | 1.375.000 | 1,22% | Azioni |
| PERCEPTIVE ADVISORS LLC | $52.299.967 | 1.357.383 | 1,20% | Azioni |
| D. E. Shaw & Co., Inc. | $47.802.399 | 1.240.654 | 1,10% | Azioni |
| ARMISTICE CAPITAL, LLC | $46.236.000 | 1.200.000 | 1,06% | Opzione Call |
| BANK OF AMERICA CORP /DE/ | $45.521.345 | 1.181.452 | 1,05% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $39.397.426 | 1.022.513 | 0,90% | Azioni |
| Aberdeen Group plc | $33.021.366 | 857.030 | 0,76% | Azioni |
| NORTHERN TRUST CORP | $30.592.975 | 794.004 | 0,70% | Azioni |
| RENAISSANCE TECHNOLOGIES LLC | $28.003.604 | 726.800 | 0,64% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $26.223.210 | 680.592 | 0,60% | Azioni |
| Logos Global Management LP | $25.622.450 | 665.000 | 0,59% | Azioni |
| SILVERARC CAPITAL MANAGEMENT, LLC | $23.853.769 | 619.096 | 0,55% | Azioni |
| Nuveen, LLC | $23.196.833 | 602.046 | 0,53% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $21.740.398 | 564.246 | 0,50% | Azioni |
| Connor, Clark & Lunn Investment Management Ltd. | $18.262.604 | 473.984 | 0,42% | Azioni |
| UBS Group AG | $18.190.861 | 472.122 | 0,42% | Azioni |
| Pictet Asset Management Holding SA | $17.814.692 | 462.359 | 0,41% | Azioni |
| MILLENNIUM MANAGEMENT LLC | $12.663.963 | 328.678 | 0,29% | Azioni |
| BNP PARIBAS FINANCIAL MARKETS | $12.332.336 | 320.071 | 0,28% | Azioni |
| JANE STREET GROUP, LLC | $11.959.712 | 310.400 | 0,27% | Opzione Call |
| Bank of New York Mellon Corp | $11.396.826 | 295.791 | 0,26% | Azioni |
| HighVista Strategies LLC | $10.706.447 | 277.873 | 0,25% | Azioni |
| STEMPOINT CAPITAL LP | $10.654.585 | 276.527 | 0,24% | Azioni |
| Tetragon Partners GP Ltd | $9.861.137 | 255.934 | 0,23% | Azioni |
| Soleus Capital Management, L.P. | $9.709.560 | 252.000 | 0,22% | Azioni |
| SUPERSTRING CAPITAL MANAGEMENT LP | $8.028.419 | 208.368 | 0,18% | Azioni |
| Granahan Investment Management, LLC | $7.951.513 | 206.372 | 0,18% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $7.050.990 | 183.000 | 0,16% | Opzione Call |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $6.288.096 | 163.200 | 0,14% | Opzione Put |
| CITADEL ADVISORS LLC | $6.169.539 | 160.123 | 0,14% | Azioni |
| ALGERT GLOBAL LLC | $6.158.635 | 159.840 | 0,14% | Azioni |
Attivisti e proprietari del 5%+ 2 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| Roivant Sciences Ltd. ×11 depositi | 12 Dicembre 2025 | 55,90% | Modifica | · | SEC |
| Roderick Wong, M.D. | 27 Dicembre 2019 | · | Deposito iniziale | M&A / vendita | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insider aziendali 27 insider · 17 dirigenti · 12 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Eric Venker | Chief Executive Officer | 01 Luglio 2026 M | 254.280 | 0 | 3 | $-461.834 |
| Peter Salzmann | Chief Executive Officer | 16 Aprile 2025 S | 1.178.191 | 0 | 0 | $0 |
| Roderick Wong, M.D. | Chief Executive Officer | 11 Dicembre 2019 P | 902.498 | 0 | 0 | $0 |
| Tiago Girao | Chief Financial Officer | 23 Luglio 2026 S | 240.798 | 0 | 3 | $-1.410.626 |
| Eva Renee Barnett | Chief Financial Officer | 16 Aprile 2025 S | 396.774 | 0 | 0 | $0 |
| Connealy Pamela Yanchik | Chief Financial Officer | 19 Marzo 2021 A | 46.200 | 0 | 0 | $0 |
| Melanie Gloria | Chief Operating Officer | 20 Agosto 2026 S | 219.301 | 0 | 14 | $-1.600.150 |
| Christopher Van Tuyl | Chief Legal Officer | 23 Settembre 2026 S | 176.545 | 0 | 10 | $-1.418.316 |
| Jay S Stout | Chief Technology Officer | 23 Luglio 2026 S | 205.341 | 0 | 15 | $-2.271.089 |
| Michael Geffner | Chief Medical Officer | 22 Ottobre 2025 S | 217.958 | 0 | 2 | $-70.117 |
| William L. Macias | Chief Medical Officer | 19 Febbraio 2025 S | 357.353 | 0 | 0 | $0 |
| Mark S. Levine | Chief Legal Officer | 20 Novembre 2024 S | 319.228 | 0 | 0 | $0 |
| Julia G. Butchko | Chief Development Officer | 21 Agosto 2024 S | 440.959 | 0 | 0 | $0 |
| Michael James Elliott | Chief Scientific Officer | 19 Marzo 2021 A | 97.600 | 0 | 0 | $0 |
| Rita Jain | Chief Medical Officer | 19 Marzo 2021 A | 129.365 | 0 | 0 | $0 |
| Bradford W Middlekauff | General Counsel | 15 Maggio 2020 A | · | 0 | 0 | $0 |
| Robert K Zeldin | Chief Medical Officer | 18 Dicembre 2019 A | · | 0 | 0 | $0 |
| Atul Pande | Direttore | 28 Agosto 2026 M | 116.731 | 0 | 5 | $-424.650 |
| Andrew J. Fromkin | Direttore | 28 Maggio 2026 M | 74.382 | 0 | 4 | $-7.955.300 |
| Robert Graham Susman | Direttore | 01 Maggio 2026 S | 36.394 | 0 | 1 | $-67.979 |
| Douglas J. Hughes | Direttore | 07 Aprile 2026 A | 134.653 | 0 | 2 | $-348.666 |
| Jake Bauer | Direttore | 07 Aprile 2026 A | 38.896 | 0 | 0 | $0 |
| Frank Torti | Direttore | 07 Aprile 2026 A | 1.009.228 | 0 | 0 | $0 |
| Roivant Sciences Ltd. | Direttore | 12 Dicembre 2025 P | 113.317.007 | 1 | 0 | $349.999.986 |
| George V Migausky | Direttore | 01 Aprile 2025 A | 137.251 | 0 | 0 | $0 |
| Myrtle S Potter | Direttore | 18 Dicembre 2019 A | · | 0 | 0 | $0 |
| Health Sciences Holdings, LLC | Proprietario del 10% | 18 Dicembre 2019 J | · | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduti da 33 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| GURU · Global X Funds | 1,59% | 25.151 NS | 31 Luglio 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,77% | 9.245 NS | 31 Luglio 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,68% | 87.318 NS | 31 Luglio 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,46% | 14.619 SH | 01 Ottobre 2026 | Giornaliero |
| ESSC · Strategy Shares | 0,34% | 3.180 NS | 31 Luglio 2026 | N-PORT |
| IBB · iShares Trust | 0,23% | 618.035 SH | 11 Settembre 2026 | Giornaliero |
| IWO · iShares Trust | 0,21% | 801.227 SH | 11 Settembre 2026 | Giornaliero |
| PWS · Pacer Funds Trust | 0,19% | 1.193 NS | 31 Luglio 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,19% | 91.474 SH | 19 Agosto 2026 | Giornaliero |
| BKSE · BNY Mellon ETF Trust | 0,14% | 3.097 NS | 31 Luglio 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,13% | 23.292 NS | 31 Luglio 2026 | N-PORT |
| ISCG · iShares Trust | 0,11% | 27.234 SH | 11 Settembre 2026 | Giornaliero |
| IWM · iShares Trust | 0,11% | 2.184.173 SH | 11 Settembre 2026 | Giornaliero |
| RSSL · Global X Funds | 0,11% | 40.851 NS | 31 Luglio 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,10% | 490.917 SH | 19 Agosto 2026 | Giornaliero |
| VBK · VANGUARD INDEX FUNDS | 0,09% | 1.086.290 SH | 19 Agosto 2026 | Giornaliero |
| VFMO · VANGUARD WELLINGTON FUND | 0,05% | 28.526 SH | 19 Agosto 2026 | Giornaliero |
| VB · VANGUARD INDEX FUNDS | 0,04% | 1.883.385 SH | 19 Agosto 2026 | Giornaliero |
| VHT · VANGUARD WORLD FUND | 0,04% | 199.146 SH | 19 Agosto 2026 | Giornaliero |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,04% | 31.197 SH | 01 Ottobre 2026 | Giornaliero |
| FHLC · FIDELITY COVINGTON TRUST | 0,04% | 31.435 NS | 31 Luglio 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,03% | 887.661 SH | 19 Agosto 2026 | Giornaliero |
| WSML · iShares Trust | 0,02% | 4.355 SH | 11 Settembre 2026 | Giornaliero |
| ESGV · VANGUARD WORLD FUND | 0,01% | 18.937 SH | 19 Agosto 2026 | Giornaliero |
| ITOT · iShares Trust | 0,00% | 116.576 SH | 11 Settembre 2026 | Giornaliero |
| IWV · iShares Trust | 0,00% | 24.022 SH | 10 Settembre 2026 | Giornaliero |
| TILT · FlexShares Trust | 0,00% | 2.430 NS | 31 Luglio 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2.600.899 SH | 19 Agosto 2026 | Giornaliero |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 67.319 SH | 19 Agosto 2026 | Giornaliero |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 7.098 SH | 19 Agosto 2026 | Giornaliero |
| DFAS · Dimensional ETF Trust | 0,00% | 18 NS | 31 Luglio 2026 | N-PORT |
| ISCB · iShares Trust | · | 3.864 SH | 11 Settembre 2026 | Giornaliero |
| SMLF · iShares Trust | · | 16.335 SH | 11 Settembre 2026 | Giornaliero |
IMVT Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
rating · 23 analisti
COMPRA
Target mediano
$48.50
+44,3%
9 39,1%
Acquisto forte
9 39,1%
Compra
5 21,7%
Mantieni
0 0,0%
Vendi
0 0,0%
Vendita forte
Target Price a 12 Mesi
16 analisti · 2026-09-28Target medio $48.88 +45,4%
Ora
Prezzo attuale $33.62
Basso$30.00
Media$48.88
Alto$66.00
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| IMVT | $5.07B | -9.0 | 229.2% | · | -73.7% | · |
| SYRE | $2.56B | 10.1 | -62.0% | · | -26.5% | · |
| CAI | $7.62B | -8.4 | 97.0% | -8.4% | -13.2% | · |
| IONS | $12.92B | -33.2 | · | · | -68.1% | · |
| RYTM | $7.19B | -34.4 | 45.8% | -103.6% | -309.1% | · |
| IOVA | $1.12B | -2.5 | 60.6% | -148.4% | -56.0% | · |
| GRAL | $3.45B | -7.7 | 17.2% | -277.5% | -16.7% | · |
| CGON | $3.35B | -20.0 | 254.7% | -3985.0% | -22.6% | · |
| SRRK | $4.78B | -13.4 | · | · | -157.9% | · |
Ultime notizie Notizie recenti che menzionano questa società
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Fonte: SEC 10-Q depositato Ago 6, 2026